Charles Schwab’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $480K | Buy |
177,249
+147,262
| +491% | +$399K | ﹤0.01% | 3152 |
|
|
2025
Q1 | $102K | Hold |
29,987
| – | – | ﹤0.01% | 3343 |
|
|
2024
Q4 | $124K | Buy |
29,987
+15,000
| +100% | +$61.8K | ﹤0.01% | 3382 |
|
|
2024
Q3 | $37.3K | Hold |
14,987
| – | – | ﹤0.01% | 3442 |
|
|
2024
Q2 | $39.6K | Hold |
14,987
| – | – | ﹤0.01% | 3533 |
|
|
2024
Q1 | $30.9K | Hold |
14,987
| – | – | ﹤0.01% | 3409 |
|
|
2023
Q4 | $27K | Hold |
14,987
| – | – | ﹤0.01% | 3459 |
|
|
2023
Q3 | $20.5K | Hold |
14,987
| – | – | ﹤0.01% | 3511 |
|
|
2023
Q2 | $20.5K | Hold |
14,987
| – | – | ﹤0.01% | 3556 |
|
|
2023
Q1 | $35.4K | Buy |
+14,987
| New | +$35.4K | ﹤0.01% | 3416 |
|
|
2017
Q2 | – | Sell |
-93
| Closed | -$13K | – | 3111 |
|
|
2017
Q1 | $13K | Hold |
93
| – | – | ﹤0.01% | 3052 |
|
|
2016
Q4 | $15K | Hold |
93
| – | – | ﹤0.01% | 3073 |
|
|
2016
Q3 | $23K | Hold |
93
| – | – | ﹤0.01% | 3032 |
|
|
2016
Q2 | $83K | Sell |
93
-17
| -15% | -$15.2K | ﹤0.01% | 3067 |
|
|
2016
Q1 | $101K | Hold |
110
| – | – | ﹤0.01% | 2991 |
|
|
2015
Q4 | $157K | Hold |
110
| – | – | ﹤0.01% | 3001 |
|
|
2015
Q3 | $186K | Buy |
+110
| New | +$186K | ﹤0.01% | 2967 |
|